[ Price : $8.95]
The Peggy Lillis C. diff foundation asks FDA to take specific actions to improve the availability of microbiome treatments for C. ...[ Price : $8.95]
FDA notifies Histogen verbally of a coming clinical hold on its planned Phase 1/2 trial of HST-003.[ Price : $8.95]
Federal Register notice: FDA issues a final rule to provide additional information on the content and format of reports intended t...[ Price : $8.95]
FDA defers a review action on GlaxoSmithKlines PD-1 drug dostarlimab, indicated for treating endometrial cancer, because it could ...[ Price : $8.95]
A Vanity Fair special report examines how former FDA commissioner Stephen Hahn became the most politicized commissioner in recent ...[ Price : $8.95]
FDA clears an Eitan Medical 510(k) for its upgraded Sapphire infusion pump system and software Rev15, which includes pump, adminis...[ Price : $8.95]
L.E.K. consulting says better product launches are a key to profits in drug development over the last 15 years.[ Price : $8.95]
Federal Register Final Rule: HHS issues a final rule under the Regulatory Flexibility Act that requires agencies like FDA to publi...